Annual Current Liabilities
$2.04 M
+$774.90 K+61.33%
December 1, 2023
Summary
- As of March 12, 2025, BLAC annual total current liabilities is $2.04 million, with the most recent change of +$774.90 thousand (+61.33%) on December 1, 2023.
- During the last 3 years, BLAC annual current liabilities has risen by +$1.72 million (+533.80%).
Performance
BLAC Current Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Quarterly Current Liabilities
$3.94 M
+$523.00 K+15.30%
September 1, 2024
Summary
- As of March 12, 2025, BLAC quarterly total current liabilities is $3.94 million, with the most recent change of +$523.00 thousand (+15.30%) on September 1, 2024.
- Over the past year, BLAC quarterly current liabilities has stayed the same.
Performance
BLAC Quarterly Current Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Current Liabilities Formula
Current Liabilities = Accounts Payable + Short-Term Debt + Accrued Expenses + Other Current Liabilities
BLAC Current Liabilities Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +61.3% | 0.0% |
| 3 y3 years | +533.8% | 0.0% |
| 5 y5 years | +533.8% | 0.0% |
BLAC Current Liabilities Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | -65.3% | at high | -89.8% |
| 5 y | 5-year | at high | -84.2% | at high | -89.8% |
| alltime | all time | at high | -84.2% | at high | -89.8% |
Bellevue Life Sciences Acquisition Current Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $3.94 M(+15.3%) |
| Jun 2024 | - | $3.42 M(+24.5%) |
| Mar 2024 | - | $2.75 M(+34.7%) |
| Dec 2023 | $2.04 M | $2.04 M(+84.4%) |
| Sep 2023 | - | $1.11 M(+104.1%) |
| Jun 2023 | - | $541.40 K(+34.2%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2023 | - | $403.40 K(-68.1%) |
| Dec 2022 | $1.26 M(+78.6%) | $1.26 M(+6.6%) |
| Sep 2022 | - | $1.19 M(+11.6%) |
| Jun 2022 | - | $1.06 M(+50.2%) |
| Dec 2021 | $707.20 K(+119.9%) | $707.20 K |
| Dec 2020 | $321.60 K | - |
FAQ
- What is Bellevue Life Sciences Acquisition annual total current liabilities?
- What is the all time high annual current liabilities for Bellevue Life Sciences Acquisition?
- What is Bellevue Life Sciences Acquisition annual current liabilities year-on-year change?
- What is Bellevue Life Sciences Acquisition quarterly total current liabilities?
- What is the all time high quarterly current liabilities for Bellevue Life Sciences Acquisition?
- What is Bellevue Life Sciences Acquisition quarterly current liabilities year-on-year change?
What is Bellevue Life Sciences Acquisition annual total current liabilities?
The current annual current liabilities of BLAC is $2.04 M
What is the all time high annual current liabilities for Bellevue Life Sciences Acquisition?
Bellevue Life Sciences Acquisition all-time high annual total current liabilities is $2.04 M
What is Bellevue Life Sciences Acquisition annual current liabilities year-on-year change?
Over the past year, BLAC annual total current liabilities has changed by +$774.90 K (+61.33%)
What is Bellevue Life Sciences Acquisition quarterly total current liabilities?
The current quarterly current liabilities of BLAC is $3.94 M
What is the all time high quarterly current liabilities for Bellevue Life Sciences Acquisition?
Bellevue Life Sciences Acquisition all-time high quarterly total current liabilities is $3.94 M
What is Bellevue Life Sciences Acquisition quarterly current liabilities year-on-year change?
Over the past year, BLAC quarterly total current liabilities has changed by $0.00 (0.00%)